L19IL2 or L19TNF or L19IL2/TNF in Patients With Basal Cell Carcinoma (BCC)

Abroad (travel likely)RecruitingPHASE2

Conditions

Locally Advanced Basal Cell Carcinoma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

H. Lee Moffitt Cancer Center and Research Institute Hospital, Inc., Tampa, Florida, United States
Contact: Principal Investigator (Jonathan S Zager, MD)
Winship Cancer Institute, Emory University, Atlanta, Georgia, United States
Contact: Principal Investigator (Michael C. Lowe, MD)
The University of Texas MD Anderson Cancer Center, Houston, Texas, United States
Contact: Principal Investigator (Michael R Migden, MD)

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Nivolumab Alone or Plus Relatlimab or Ipilimumab for Patients With Locally-Advanced Unresectable or Metastatic Basal Cell Carcinoma

Basal Cell Carcinoma

Abroad (travel likely)RecruitingPHASE2

Baltimore, United States

Radiotherapy by Sonic Hedgehog Pathway Inhibitors in Basal Cell Carcinoma

Basal Cell Carcinoma · Radiotherapy; Complications

Abroad (travel likely)RecruitingPHASE2

Lille, France

A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors

Advanced Solid Tumors · Genital Neoplasm, Female · Urogenital Neoplasms

Abroad (travel likely)RecruitingPHASE1, PHASE2

Loma Linda, United States · Sacramento, United States

To Assess the Safety and Efficacy of SP-002 with Vismodegib for the Treatment of Locally Advanced Basal Cell Carcinoma

Basal Cell Carcinoma

Abroad (travel likely)RecruitingPHASE2

Phoenix, United States · Boca Raton, United States